Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).

Specializing in recombinant and traditional chromogenic and turbidimetric reagent technologies, ACC has been a global leader in endotoxin and (1→3)-ß-D-glucans detection products and services for 50 years. ACC pioneered LAL testing methodology and was the first FDA licensed company to manufacture LAL reagents; ACC has grown to be an internationally recognized leader in endotoxin detection. We are headquartered in Falmouth, MA with facilities in the UK and the Netherlands. With a dedication to quality, ACC is certified to I.S. EN ISO 13485:2016 and ISO 13485:2016. We are FDA inspected and operate DEA Licensed and CLIA-certified laboratories. Our endotoxin detection reagents, instruments and software are used within the Pharmaceutical, Medical-Device, Biotechnology, Compounding Pharmacy and Dialysis industries for quality control, product release and research. ACC operates a Contract Test Services (CTS) Laboratory which has specialized in testing for endotoxin contamination for over 40 years. Our CTS laboratory is GMP compliant, ISO registered and DEA licensed and is capable of handling all controlled drug substances except those included in Schedule 1. All testing services can be performed to FDA, USP, EP and/or JP regulatory guidelines. In addition to routine testing, our CTS Laboratory will customize endotoxin testing, troubleshoot difficult samples, develop and/or transfer LAL test methods, design and produce custom depyrogenation controls for oven validation and perform Low Endotoxin Recovery (LER) studies/protocols. ACC also offers a clinical diagnostics product line and operates a CLIA-certified laboratory specializing in (1→3)-ß-D-glucan analysis to support the early diagnosis of Invasive Fungal Infection (IFI). For more information please visit https://www.linkedin.com/in/fungitell-assay-3269a2154/

For more than 140 years, Bradford has helped companies build great brands by creating innovative solid cleansing and personal care products. We are the world’s leading manufacturer of specialty bar soap and cleansing poufs. Our product portfolio also includes cleansing sticks, solid shampoos and conditioners, bath bombs, and moisturizing sticks. We create original formulations through our vertical integration and kettle process; a process which allows us to truly customize our products to each brand and customer. Our broad customer base and extensive market research give us the ability to spot and predict trends in real time. We use this knowledge to innovate and deliver products and formulations that are on brand and on trend. Headquartered in Rhode Island, Bradford also has facilities in Indiana and California as well as a strategic partnership with a facility in Mexicali, Mexico.